About this trial

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.

Eligibility criteria

Qualifiers

All patients older than 18 years, admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group)

All patients older than 18 years, admitted to ICU for respiratory distress due to community- acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group)

Disqualifiers

Age < 18 years old

Pregnant women

No informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

45 Participants
are grouped into 2 trial groups

Locations

1
Universitaire Ziekenhuizen Leuven3000, Leuven Belgium

Sponsors and collaborators

Universitaire Ziekenhuizen KU Leuven

Lead sponsor